89 related articles for article (PubMed ID: 26179426)
1. Quantitative detection of circulating tumor-derived mitochondrial NADH subunit variants as a potential prognostic biomarker for oral cancer.
Uzawa K; Kasamatsu A; Baba T; Kimura Y; Nakashima D; Higo M; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H
Int J Oncol; 2015 Sep; 47(3):1077-83. PubMed ID: 26179426
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.
Uzawa K; Baba T; Uchida F; Yamatoji M; Kasamatsu A; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
Oncotarget; 2012 Jul; 3(7):670-7. PubMed ID: 22832574
[TBL] [Abstract][Full Text] [Related]
3. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers.
Tan DJ; Chang J; Chen WL; Agress LJ; Yeh KT; Wang B; Wong LJ
Genes Chromosomes Cancer; 2003 Jun; 37(2):186-94. PubMed ID: 12696067
[TBL] [Abstract][Full Text] [Related]
4. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in oral squamous cell carcinoma: An insight.
Prakruthi BV; Babu NC
Indian J Cancer; 2015; 52(2):232-4. PubMed ID: 26853418
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2b receptor promotes progression of human oral cancer.
Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921
[TBL] [Abstract][Full Text] [Related]
7. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of circulating MT-ND1 as a potential biomarker for colorectal cancer.
Xu Y; Zhou J; Yuan Q; Su J; Li Q; Lu X; Zhang L; Cai Z; Han J
Bosn J Basic Med Sci; 2021 Oct; 21(5):577-586. PubMed ID: 33823124
[TBL] [Abstract][Full Text] [Related]
10. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.
Oliveira-Costa JP; de Carvalho AF; da Silveira da GG; Amaya P; Wu Y; Park KJ; Gigliola MP; Lustberg M; Buim ME; Ferreira EN; Kowalski LP; Chalmers JJ; Soares FA; Carraro DM; Ribeiro-Silva A
Oncotarget; 2015 Aug; 6(25):20902-20. PubMed ID: 26041877
[TBL] [Abstract][Full Text] [Related]
11. Mutations in circulating mitochondrial DNA: Cassandra of oral cancer?
Kandel ES
Oncotarget; 2012 Jul; 3(7):664-5. PubMed ID: 22837433
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies.
Shiiba M; Saito K; Yamagami H; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
Int J Oncol; 2015 May; 46(5):1978-84. PubMed ID: 25738940
[TBL] [Abstract][Full Text] [Related]
14. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Zhao C; Zou H; Wang J; Shen J; Liu H
DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
[TBL] [Abstract][Full Text] [Related]
15. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis.
Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kato Y; Saito K; Nakashima D; Higo M; Kouzu Y; Ono K; Ogawara K; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Br J Cancer; 2007 Sep; 97(6):792-801. PubMed ID: 17726464
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel cell lines established from three human oral squamous cell carcinomas.
Lee G; Kim YB; Kim JH; Kim MS; Shin KH; Won YS; Lee JI; Choung PH; Hyun BH; Min BM
Int J Oncol; 2002 Jun; 20(6):1151-9. PubMed ID: 12011992
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
18. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
20. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.
Mikami Y; Fujii S; Nagata K; Wada H; Hasegawa K; Abe M; Yoshimoto RU; Kawano S; Nakamura S; Kiyoshima T
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1381-1393. PubMed ID: 28342001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
